Objective: The objective of this study was to longitudinally evaluate maternal echocardiographic findings in uncomplicated twin gestations according to chorionicity. Methods: Healthy women with twin pregnancy were assessed with transthoracic echocardiography across the first, second, and third trimesters. Cardiac findings were compared within each group and between monochorionic (MC) and dicho-rionic (DC) pregnancies. Results: Overall, 19 MC and 48 DC uncomplicated twin pregnancies were included. In the MC group, no significant maternal haemodynamic changes were documented across gestation, with the exception of a decrease in ejection fraction. Compared to DC pregnancies, in the MC set lower cardiac output (second and third trimester, p = 0.001 and p = 0.006, respectively) and higher total vascular resistance (first trimester, p = 0.032) were observed. Regarding the diastolic function in MC twins, significantly higher values were observed for mitral E/A ratio (third trimester, p = 0.014), septal mitral E1/A1 ratio (third trimester, p = 0.030), lateral mitral E1 (second and third trimester, p = 0.014 and p = 0.029, respectively), and E1/A1 ratio (third trimester, p = 0.006). Conclusions: Maternal cardiac adaptation in twin pregnancy seems to differ significantly according to chorionicity. In particular, in MC pregnancies the impairment of diastolic function is less pronounced, presumably due to the lower circulating volume.

1.
Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, Casey BM, Sheffield JS: Maternal physiology; in: Williams Obstetrics, 24th Edition. New York, McGraw-Hill, 2014, pp 46–77.
2.
Rovinsky JJ, Jaffin H: Cardiovascular hemodynamics in pregnancy. 2. Cardiac output and left ventricular work in multiple pregnancy. Am J Obstet Gynecol 1966; 95: 781–786.
3.
Veille JC, Morton MJ, Burry KJ: Maternal cardiovascular adaptations to twin pregnancy. Am J Obstet Gynecol 1985; 153: 261–263.
4.
Campbell DM, Campbell AJ: Arterial blood pressure – the pattern of change in twin pregnancies. Acta Genet Med Gemellol (Roma) 1985; 34: 217–223.
5.
Robson SC, Hunter S, Boys RJ, Dunlop W: Hemodynamic changes during twin pregnancy. A Doppler and M-mode echocardiographic study. Am J Obstet Gynecol 1989; 161: 1273–1278.
6.
Thomsen JK, Fogh-Andersen N, Jaszczak P: Atrial natriuretic peptide, blood volume, aldosterone, and sodium excretion during twin pregnancy. Acta Obstet Gynecol Scand 1994; 73: 14–20.
7.
Kametas NA, McAuliffe F, Krampl E, Chambers J, Nicolaides KH: Maternal cardiac function in twin pregnancy. Obstet Gynecol 2003; 102: 806–815.
8.
Kuleva M, Youssef A, Maroni E, Contro E, Pilu G, Rizzo N, Pelusi G, Ghi T: Maternal cardiac function in normal twin pregnancy: a longitudinal study. Ultrasound Obstet Gynecol 2011; 38: 575–580.
9.
Ghi T, Degli Esposti D, Montaguti E, Rosticci M, Tancredi S, Youssef A, di Giovanni MV, Pilu G, Borghi C, Rizzo N: Maternal cardiac evaluation during uncomplicated twin pregnancy with emphasis on the diastolic function. Am J Obstet Gynecol 2015; 213: 376.e1–e8.
10.
Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW: 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiolo gy Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977–2016.
11.
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solo mon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography: Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440–1463.
12.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453–1457.
13.
Wood PW, Choy JB, Nanda NC, Becher H: Left ventricular ejection fraction and volumes: it depends on the imaging method. Echocardiography 2014; 31: 87–100.
14.
Mangano DT, van Dyke DC, Ellis RJ: The effect of increasing preload on ventricular output and ejection in man. Limitations of the Frank-Starling mechanism. Circulation 1980; 62: 535–541.
15.
Foo JY, Mangos GJ, Brown MA: Characteristics of hypertensive disorders in twin versus singleton pregnancies. Pregnancy Hypertens 2013; 3: 3–9.
16.
Sibai BM, Hauth J, Caritis S, Lindheimer MD, MacPherson C, Klebanoff M, VanDorsten JP, Landon M, Miodovnik M, Paul R, Meis P, Thurnau G, Dombrowski M, Roberts J, McNellis D: Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000; 182: 938–942.
17.
Obiechina NJ, Okolie V, Eleje G, Okechukwu Z, Anemeje O: Twin versus singleton pregnancies: the incidence, pregnancy complications, and obstetric outcomes in a Nigerian tertiary hospital. Int J Womens Health 2011; 3: 227–230.
18.
MacKay AP, Berg CJ, King JC, Duran C, Chang J: Pregnancy-related mortality among women with multifetal pregnancies. Obstet Gynecol 2006; 107: 563–568.
19.
Bello N, Rendon ISH, Arany Z: The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol 2013; 62: 1715–1723.
20.
Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A: Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005; 111: 2050–2055.
21.
Elkayam U: Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 2011; 58: 659–670.
22.
Carlin AJ, Alfirevic Z, Gyte GM: Interventions for treating peripartum cardiomyop-athy to improve outcomes for women and babies. Cochrane Database Syst Rev 2010; 9: CD008589.
23.
Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP, Lim KH, Bdolah-Abram T, Epstein FH, Karumanchi SA: Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol 2008; 198: 428.e1–e6.
24.
Sarno L, Maruotti GM, Donadono V, Saccone G, Martinelli P: Risk of preeclampsia: comparison between dichorionic and monochorionic twin pregnancies. J Matern Fetal Neonatal Med 2014; 27: 1080–1081.
25.
Bartnik P, Kosinska-Kaczynska K, Kacper-czyk J, Ananicz W, Sierocińska A, Wielgos M, Szymusik I: Twin chorionicity and the risk of hypertensive disorders: gestational hypertension and pre-eclampsia. Twin Res Hum Ge net 2016; 19: 377–382.
26.
Thilaganathan B: Placental syndromes: getting to the heart of the matter. Ultrasound Obstet Gynecol 2017; 49: 7–9.
27.
Melchiorre K, Sutherland GR, Baltabaeva A, Liberati M, Thilaganathan B: Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension 2011; 57: 85–93.
28.
Melchiorre K, Sharma S, Thilaganathan B: Cardiovascular implications in preeclampsia: an overview. Circulation 2014; 130: 701–714.
29.
Bamfo JE, Kametas NA, Nicolaides KH, Chambers JB: Maternal left ventricular diastolic and systolic long-axis function during normal pregnancy. Eur J Echocardiogr 2007; 8: 360–368.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.